ES
ABEO icon

Equitec Specialists’s Abeona Therapeutics ABEO Stock Holding History

Equitec Specialists’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-2,930
Closed -$253K – 106
2014
Q4 		$253K Buy
+2,930
New +$263K 0.07% 59

Other funds holding ABEO

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SFM
Soros Fund Management New York $8.14B AUM 35.85% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return

Equitec Specialists's ABEO Position: Q1 2015 in Review

Equitec Specialists sold out of Abeona Therapeutics (ABEO) in Q1 2015, closing a stake of 2,930 shares — an estimated $253K sold.

Equitec Specialists first reported a position in ABEO in Q4 2014 and held it in 1 quarter. The position peaked at $253K in Q4 2014. 12 funds tracked by Wall St. Rank hold ABEO as of Q1 2015.

  • Equitec Specialists reported no remaining Abeona Therapeutics position as of Q1 2015 after selling out during the quarter.
  • Equitec Specialists sold 2,930 Abeona Therapeutics shares in Q1 2015, an estimated $253K.
  • Equitec Specialists first reported a position in Abeona Therapeutics in Q4 2014 and held it in 1 quarter.
  • Equitec Specialists's Abeona Therapeutics position peaked at $253K in Q4 2014.
  • 12 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2015.

Based on Equitec Specialists's 13F filing for Q1 2015, filed 7 May 2015.